DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition.

Abstract

Chemoresistance limits treatment efficacy in gastric cancer and doxorubicin resistance is common in gastric cancer cells. Dual specificity phosphatase 4 (DUSP4) has been associated with tumor progression. This study aimed to investigate the mechanism of DUSP4 regulating doxorubicin resistance in gastric cancer cells. Cell Counting Kit-8 (CCK-8) and 5-ethynyl-2'-deoxyuridine (EdU) incorporation assay were used to measure cell viability and proliferation in gastric cancer cells treated with doxorubicin. The expression of DUSP4, E-cadherin and Vimentin protein was detected by Western blotting. Overexpression of DUSP4 was more resistant to doxorubicin in gastric cancer cells. Knockdown of DUSP4 increased the sensitivity of gastric cancer cells to doxorubicin. Moreover, up-regulation of DUSP4 promoted the Epithelial-Mesenchymal Transition (EMT) in gastric cancer cells, but blocking the EMT using a Twist siRNA increased the sensitivity of gastric cancer cells to doxorubicin and confirmed the EMT was involved in DUSP4-mediated doxorubicin resistance. These findings demonstrated that DUSP4 could enhance doxorubicin resistance by promoting EMT in gastric cancer cells.

• Authors: Xing Kang, Minhuan Li, Hao Zhu, Xiaofeng Lu, Ji Miao, Shangce Du, Xuefeng Xia, Wenxian Guan
• Journal: Oncotarget (Oncotarget) Vol. 8 Issue 55 Pg. 94028-94039 (Nov 07 2017) ISSN: 1949-2553 [Electronic] United States
• PMID: 29212207 (Publication Type: Journal Article)